These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


208 related items for PubMed ID: 25409575

  • 1. Differential sensitivity of TREK-1, TREK-2 and TRAAK background potassium channels to the polycationic dye ruthenium red.
    Braun G, Lengyel M, Enyedi P, Czirják G.
    Br J Pharmacol; 2015 Apr; 172(7):1728-38. PubMed ID: 25409575
    [Abstract] [Full Text] [Related]

  • 2. Characterization of temperature-sensitive leak K+ currents and expression of TRAAK, TREK-1, and TREK2 channels in dorsal root ganglion neurons of rats.
    Viatchenko-Karpinski V, Ling J, Gu JG.
    Mol Brain; 2018 Jul 06; 11(1):40. PubMed ID: 29980241
    [Abstract] [Full Text] [Related]

  • 3. Chemically Modified Derivatives of the Activator Compound Cloxyquin Exert Inhibitory Effect on TRESK (K2P18.1) Background Potassium Channel.
    Lengyel M, Erdélyi F, Pergel E, Bálint-Polonka Á, Dobolyi A, Bozsaki P, Dux M, Király K, Hegedűs T, Czirják G, Mátyus P, Enyedi P.
    Mol Pharmacol; 2019 Jun 06; 95(6):652-660. PubMed ID: 30979812
    [Abstract] [Full Text] [Related]

  • 4. Thermosensitivity of the two-pore domain K+ channels TREK-2 and TRAAK.
    Kang D, Choe C, Kim D.
    J Physiol; 2005 Apr 01; 564(Pt 1):103-16. PubMed ID: 15677687
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Formation of Functional Heterodimers by TREK-1 and TREK-2 Two-pore Domain Potassium Channel Subunits.
    Lengyel M, Czirják G, Enyedi P.
    J Biol Chem; 2016 Jun 24; 291(26):13649-61. PubMed ID: 27129242
    [Abstract] [Full Text] [Related]

  • 8. Protein and Chemical Determinants of BL-1249 Action and Selectivity for K2P Channels.
    Pope L, Arrigoni C, Lou H, Bryant C, Gallardo-Godoy A, Renslo AR, Minor DL.
    ACS Chem Neurosci; 2018 Dec 19; 9(12):3153-3165. PubMed ID: 30089357
    [Abstract] [Full Text] [Related]

  • 9. GI-530159, a novel, selective, mechanosensitive two-pore-domain potassium (K2P ) channel opener, reduces rat dorsal root ganglion neuron excitability.
    Loucif AJC, Saintot PP, Liu J, Antonio BM, Zellmer SG, Yoger K, Veale EL, Wilbrey A, Omoto K, Cao L, Gutteridge A, Castle NA, Stevens EB, Mathie A.
    Br J Pharmacol; 2018 Jun 19; 175(12):2272-2283. PubMed ID: 29150838
    [Abstract] [Full Text] [Related]

  • 10. Zinc and mercuric ions distinguish TRESK from the other two-pore-domain K+ channels.
    Czirják G, Enyedi P.
    Mol Pharmacol; 2006 Mar 19; 69(3):1024-32. PubMed ID: 16354767
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Ruthenium red inhibits TASK-3 potassium channel by interconnecting glutamate 70 of the two subunits.
    Czirják G, Enyedi P.
    Mol Pharmacol; 2003 Mar 19; 63(3):646-52. PubMed ID: 12606773
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Polynuclear Ruthenium Amines Inhibit K2P Channels via a "Finger in the Dam" Mechanism.
    Pope L, Lolicato M, Minor DL.
    Cell Chem Biol; 2020 May 21; 27(5):511-524.e4. PubMed ID: 32059793
    [Abstract] [Full Text] [Related]

  • 19. Activation of TREK currents by the neuroprotective agent riluzole in mouse sympathetic neurons.
    Cadaveira-Mosquera A, Ribeiro SJ, Reboreda A, Pérez M, Lamas JA.
    J Neurosci; 2011 Jan 26; 31(4):1375-85. PubMed ID: 21273422
    [Abstract] [Full Text] [Related]

  • 20. Kv1.1 channels of dorsal root ganglion neurons are inhibited by n-butyl-p-aminobenzoate, a promising anesthetic for the treatment of chronic pain.
    Beekwilder JP, O'Leary ME, van den Broek LP, van Kempen GT, Ypey DL, van den Berg RJ.
    J Pharmacol Exp Ther; 2003 Feb 26; 304(2):531-8. PubMed ID: 12538804
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.